These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Can scleromyxedema be differentiated from nephrogenic fibrosing dermatopathy by the distribution of the infiltrate? Satter EK, Metcalf JS, Maize JC. J Cutan Pathol; 2006 Nov; 33(11):756-9. PubMed ID: 17083697 [No Abstract] [Full Text] [Related]
43. Nephrogenic fibrosing dermopathy. Hidalgo Parra I, Torre A, Galimberti G, Rosa-Diez G, Malieni D, Kowalczuk A, Galimberti R. J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):875-6. PubMed ID: 18462299 [No Abstract] [Full Text] [Related]
59. Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases. Streams BN, Liu V, Liégeois N, Moschella SM. J Am Acad Dermatol; 2003 Jan; 48(1):42-7. PubMed ID: 12522369 [Abstract] [Full Text] [Related]